Reishi-MRL 90 tab (högkvalité)

I lager.
Antal: 3

300 kr

Reishi (Ganoderma Lucidum)

(Ling Zhi på kinesiska) Svamparnas konung som den också kallas. Den har många egenskaper, bl a

-den går till Hjärt, Lever och Lung meridian

-smak: söt, temperatur: neutral

-den toniserar Hjärtans Qi, när HjärtBlod och lugnar Anden (själen) 

-den toniserar Lungens Qi, omvandlar Slem och stoppar hostar och väsande

-den toniserar Qi och när Blod 


Reishi används mycket som komplement till skolmedicinsk cancerbehandling (OBS: den ersätter inte annan cancerbehandling).Det finns många kliniska studier och goda resultat för bl a bröstcancer, prostatacancer, lungcancer.

lästips: Medicinal mushrooms, A Clinical Guide, av Martin Powell

Andra egenskaper av Reishi svamp:

-inhiberar histaminutsöndring, -hepaprotective, -inhiberar ACE, -inhiberar kolesterolsyntes, -antiinflammatorisk, -inducerar apoptosi, -inhiberar viral induction, -antioxidant, -antitumör, -sederar CNS, -antimicrobiell, -immunmodulerande

Cultivation Process of Reishi-MRL™


While Mycology Research Laboratories Ltd.´s Reishi-MRL (Ganoderma lucidum) powder is not an extract of Ganoderma lucidum, the powder does contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.

This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardised production of Ganoderma lucidum. The powder biomass is then sealed in plastic containers.

The Reishi-MRL biomass contains mycelium and primordia (young fruiting body) of the respective mushroom. In comparison to Resihi extracts, biomass has the advantage of no unwanted shift of effect which happens with extracts or concentrates, including lyophilisation, and thus the activity of the product corresponds with the source mushroom, while being further intensified by utilizing the entire mycelium.

Mycelium biomass of mushrooms offers a mixture of many co-operating and co-related healthful bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.

Mushrooms spend more than 90% of their life cycle in the mycelium. Since mushrooms cannot produce their own energy through photosynthesis, the mycelium must be able to actively obtain or produce extracellular compounds and metabolites that promote the longevity and vitality of the living mushroom. These properties lie behind the high enzymatic activity of the mycelium, which stays preserved in the carefully processed MRL products.

Manufacturing Process of Reishi-MRL

Our Ganoderma lucidum is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of standardised Ganoderma lucidum product.

The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.

After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.

Certified Organic

The fungal biomass Ganoderma lucidum that comprises Reishi-MRL is certified 100% Organic in the United States by Quality Assurance International (Certificate No. 103491-A).

In December of 2005, MRL powder gained EU organic certification in accordance with EU Council Regulation (EEC) No. 2092/91 by Quality Assurance International (Certificate No. 105493-A).

Chemical and Biological Properties *

Each Tablet of Reishi-MRL contains

Ganoderma lucidum - biomass powder500 mg

Other ingredients

Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate

Reishi-MRL - Enzyme Activity Per 750 mg Tablet

Protein content22.2 mg
Reducing sugars24.0 mg
Protein-bound polysaccharide69.5 mg
Glucose 2-oxidase activity8.2 mU
Peroxidase activity11.2 mU
Laccase activity451.5 mU
Glucoamylase / beta-glucansase activity2.7 U
Protease activity4.4 mU
Superoxide dismutase (SOD) activity50.4 mU
Cytochrome P-4500.66 nmoles
Cytochrome P-450 reductase7.05 mU
Secondary metabolites (Thrombin inhibitors)4.4%